Corrigendum to 'Efficacy of allogeneic HCT in HTLV-1 associated adult T-cell leukemia/lymphoma: results of a systematic review/meta-analysis' [Biology of Blood and Marrow Transplantation 25/8 (2019) 1695-1700]
1 Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida.
2 Program for Comparative Effectiveness Research, Morsani College of Medicine, University of South Florida, Tampa, Florida.
3 Blood and Marrow Transplantation and Malignant Hematology Program, University of Florida Health Cancer Center, Gainesville, Florida.
4 Department of Internal Medicine, Division of Hematology-Oncology, American University of Beirut, Beirut, Lebanon.
5 Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida. Electronic address: kharfandabaja.mohamed@mayo.edu.